SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

KERALA AYURVEDA

BSE: 530163 29 Jun 2025
Healthcare
₹ 511.7
Kerala Ayurveda Limited specializes in Pharmaceuticals within the Healthcare sector.

KERALA AYURVEDA - Share Price & Details

Market Cap
₹582.0
High /Low
515.0 / 250.0
Stock P/E
NA
Book Value
₹20.9
Dividend Yield
0.0
ROCE
-10.3
ROE
₹-40.8
Face Value
10.0
PEG Ratio
NA
EVEBITDA
₹-85.9
Debt
55.6
CMP / FCF
-1,392
Debt to equity
₹2.21
NP Ann
-13.8
High price all time
515.0
Piotroski score
₹4.0
Graham Number
NA
No. Eq. Shares
1.2
Net CF
₹-16.1
Net profit
-13.8
Price to book value
23.2
Interest Coverage
₹-2.44
Low price all time
10.0
Industry PE
33.8
Reserves
₹13.1
Free Cash Flow
₹-4.53

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
KERALA AYURVEDA LTD.NANANANA582.0
Shukra Pharmaceuticals LimitedNANANANA57960.5
VENUS REMEDIES LTD.NANANANA57914.8

Peer Comparison Chart


About KERALA AYURVEDA

Kerala Ayurveda Limited, with Security Code 530163, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Kerala Ayurveda Ltd Share Price Today, null Share Price NSE, BSE

(13 Jun 2025)
bt_logo Peer Comparison · ₹1,687.80 · ₹6,667.00 · ₹1,505.20 · ₹1,362.50. Dr Reddys Laboratories Ltd. bt_logo Stock Summary. Face Value (₹)10.00...
Read more →

Kerala Ayurveda Reaches All-Time High Amid Strong Trading Momentum and Performance

(12 Jun 2025)
Kerala Ayurveda, a microcap in the Pharmaceuticals & Biotechnology sector, has demonstrated strong trading activity, reaching an intraday...
Read more →

Who are in the management team of Kerala Ayurveda?

(08 Jun 2025)
As of March 2022, the management team of Kerala Ayurveda includes Ramesh Vangal (Chairman), K Anilkumar (Whole-time Director),...
Read more →

Kerala Ayurveda Faces Financial Challenges Amidst Stock Resilience and Positive Technical Indicators

(07 Jun 2025)
Kerala Ayurveda has recently experienced a significant evaluation adjustment due to a decline in financial performance for the quarter ending March 2025.
Read more →

Kerala Ayurveda reports FY25 consolidated revenue higher by 22% at Rs. 137.2 Cr

(28 May 2025)
Adjusted EBITDA positive at Rs. 3.1 crore despite investments in marketing, talent hiring and technology over the year.
Read more →

Ayurvedic Preparations Market Is Booming Worldwide | Charak, Zandu, Kerala Ayurveda

(13 May 2025)
HTF MI just released the Global Ayurvedic Preparations Market Study, a comprehensive analysis of the market that spans more than 143+ pages...
Read more →